Assembly Biosciences (ASMB) EBIT Margin (2017 - 2026)
Assembly Biosciences (ASMB) recorded EBIT Margin of -47.44% in Q2 2026, up 67.80 percentage points from -115.24% a year earlier and up 91.00 percentage points from the prior quarter.
Powered by 
Analysis
Assembly Biosciences (ASMB) EBIT Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Assembly Biosciences' EBIT Margin came in at -11.75% as of Jun 30, 2026, up 119.15 percentage points year-over-year; for FY2025, it was -16.76%, up 142.50 percentage points from FY2024.
- Annual EBIT Margin has a five-year change of +65.13 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at -159.26% in FY2024 (+743.24 pp), -902.50% in FY2023 and -2121.65% in FY2021 (-2039.76 pp).
- Quarterly EBIT Margin has ranged from -301.81% in Q3 2021 to 46.62% in Q4 2025 over the past five years.
- On a year-over-year basis, EBIT Margin rose in six of the last seven quarters, with an average year-over-year change of +60.52 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 203.37 percentage points in Q4 2025, against a drop of 290.19 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -138.44% (Q1 2026), 46.62% (Q4 2025) and -100.87% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Assembly Biosciences | 468.67 Mn | -558.96 Mn | - | -47.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.44% |
| Mar 31, 2026 | -138.44% |
| Dec 31, 2025 | 46.62% |
| Sep 30, 2025 | -100.87% |
| Jun 30, 2025 | -115.24% |
| Mar 31, 2025 | -105.54% |
| Dec 31, 2024 | -156.75% |
| Sep 30, 2024 | -160.06% |
| Jun 30, 2024 | -143.01% |
| Mar 31, 2024 | -185.46% |
| Dec 31, 2023 | -175.22% |
| Sep 30, 2021 | -301.81% |
| Dec 31, 2020 | -3,822.76% |
| Sep 30, 2020 | -11.61% |
| Jun 30, 2020 | 16.71% |
| Mar 31, 2020 | -678.61% |
| Dec 31, 2019 | -601.72% |
| Sep 30, 2019 | -614.35% |
| Jun 30, 2019 | -639.61% |
| Mar 31, 2019 | -729.37% |
API Access
Assembly Biosciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ASMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ASMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ASMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();